# A quantitative genetic and epigenetic model of complex traits

- Zhong Wang
^{1, 2}, - Zuoheng Wang
^{3}, - Jianxin Wang
^{4}, - Yihan Sui
^{4}, - Jian Zhang
^{1}, - Duanping Liao
^{2}and - Rongling Wu
^{2}Email author

**13**:274

**DOI: **10.1186/1471-2105-13-274

© Wang et al.; licensee BioMed Central Ltd. 2012

**Received: **24 May 2012

**Accepted: **1 October 2012

**Published: **26 October 2012

## Abstract

### Background

Despite our increasing recognition of the mechanisms that specify and propagate epigenetic states of gene expression, the pattern of how epigenetic modifications contribute to the overall genetic variation of a phenotypic trait remains largely elusive.

### Results

We construct a quantitative model to explore the effect of epigenetic modifications that occur at specific rates on the genome. This model, derived from, but beyond, the traditional quantitative genetic theory that is founded on Mendel’s laws, allows questions concerning the prevalence and importance of epigenetic variation to be incorporated and addressed.

### Conclusions

It provides a new avenue for bringing chromatin inheritance into the realm of complex traits, facilitating our understanding of the means by which phenotypic variation is generated.

## Background

Systematic or stochastic changes in chromatin states, such as DNA methylation, chromatin remodeling, histone modification and RNA interference, have been thought to provide an additional driving force for phenotypic variation in complex traits and diseases [1–9]. Different chromatin states, called epialleles, that occur in the same sequence allele cannot be captured by an analysis based on DNA sequence alone [10]. With the increasing availability of epigenome technologies, there has been an unprecedented opportunity to understand the role of epiallelic variants in maintaining and inducing functional variation for organisms to better buffer against environmental perturbations. This hence entails the development of quantitative models that can enable our knowledge about the amount and pattern of quantitative variation determined by epialleles. By integrating with linkage or association mapping strategies, these models can retrieve epigenetic variation that cannot be estimated presently [10–13].

There have been several publications on methodological development for epigenetic detection [14–17]. Johannes and Colome-Tatche [16] proposed an experimental approach for estimating epigenetic variation in experimental crosses derived from epigenomically perturbed isogenic lines. This approach is powered to model the effects of epiallelic instability, recombination, parent-of-origin effects, and transgressive segregation on phenotypic variation across generations. Tal et al. [15] derived an expression form for covariances between relatives due to epigenetic transmissibility. A statistical model based on multiple testing procedures has been developed to identify the genomic regions of epigenetic variability among different individuals from genome-wide DNA methylation data [18]. These model developments, in a combination with empirical studies, can be used to test the hypothesis that epigenetic variation arising from chromatin modifications of DNA directly or indirectly is an important contributor to the missing heritability [17, 19].

Despite these advances, we are still unclear how much of the phenotypic variation is contributed by epigenetic modifications and, more importantly, through which way epialleles trigger their effects on phenotypic values. The motivation of this article is to develop a quantitative model for estimating and testing the contribution of epigenetic variants to quantitative trait variation. The model allows the prediction of how much genetic variation is produced through a change in the rate of occurrence of epigenetic mutation and the effect of epigenetic factors in a natural population. We particularly discuss how the epigenetic effect interacts with other genetic effects, such as additive and dominant, to affect phenotypic traits. By implementing it into genome-wide association studies [19], the model proposed provides useful guidance for designing efficient and effective molecular experiments to characterize a comprehensive picture of the epigenetic variation of complex traits or diseases in different organisms.

## Model

### Occurrence rate of methylation

Consider an epigenetic study population of *n* individuals that are randomly drawn from a natural population, in which a nucleotide site, with two alleles *A*_{1} and *A*_{2}, is thought to affect a phenotypic trait. Let *p* and *q* (*p* + *q* = 1) denote the allele frequencies of *A*_{1} and *A*_{2} in the natural population at Hardy-Weinberg equilibrium (HWE), respectively. The genotypic frequencies of *A*_{1}*A*_{1}, *A*_{1}*A*_{2}, and *A*_{2}*A*_{2} at the nucleotide site studied are expressed as *p*^{2}, 2*pq*, and *q*^{2}, respectively [20, 21].

*A*

_{1}is a cytosine which is, if any, methylated into a new “allele” called the epiallele, denoted as

*A*

_{ e }, at a rate

*u*. After DNA methylation, the population frequencies of non-methylated

*A*

_{1}allele, epiallele

*A*

_{ e }and allele

*A*

_{2}are (1 –

*u*)

*p*,

*up*, and

*q*, respectively. Current technologies allow the distinction of epialleles from non-methylated alleles. The process of methylation and the resulting frequencies of six distinguishable genetic and epigenetic types are expressed as

where *D*_{12}, *D*_{1e}, and *D*_{2e} are the coefficients of Hardy-Weinberg disequilibrium (HWD) due to a non-random association between alleles *A*_{1} and *A*_{2}, between allele *A*_{1} and epiallele *A*_{
e
}, and between allele *A*_{2} and epiallele *A*_{
e
}, respectively. It is possible that the previous equilibrium of the population is violated by DNA methylation, leading to the HWD quantified by *D*_{12}, *D*_{1e}, and *D*_{2e}. Thus, the genotype and epigenotype frequencies may be determined by allele and epiallele frequencies and HWD coefficients.

*n*

_{11},

*n*

_{1e},

*n*

_{ ee },

*n*

_{12},

*n*

_{2e}, and

*n*

_{22}(

*n*

_{11}+

*n*

_{1e}+

*n*

_{ ee }+

*n*

_{12}+

*n*

_{2e}+

*n*

_{22}=

*n*) denote the observations of the corresponding genotypes/epigenotypes (1) in the study population. Based on the frequencies of these genotypes/epigenotypes, we formulate a polynomial likelihood from which to obtain the maximum likelihood estimates (MLEs) of the allele frequencies, the occurrence frequency of methylation, and HWD using

_{0}:

*u*= 0, vs. an alternative hypothesis, H

_{0}:

*u*≠ 0, under each of which the likelihoods (L

_{0}and L

_{1}) are calculated, respectively. However, because the

*u*value in the H

_{0}lies on the boundary of parameter space, the log-likelihood ratio calculated,

may not follow a standard chi-square distribution. Self and Liang [22] showed that the null distribution of the LR test statistic is a mixture of projections of chi-square variables onto surfaces, with the weights of mixtures that can be derived analytically only in special cases. By establishing the asymptotic null and alternative distributions of quasi-likelihood ratio, rescaled quasi-likelihood ratio, Wald, and score tests, Andrews [23] suggested the use of these test statistics to test the boundary value of a model parameter. While the first three test statistics are easy to compute, the score test is more difficult by deriving the first and second-order derivatives of the alternative log-likelihood.

Similar tests can be performed for individual HWD, *D*_{1e}, *D*_{2e}, or *D*_{12}, or their combinations, by formulating the null hypotheses, respectively. Under the alternative hypothesis H_{1} associated with each null hypothesis considered, the likelihood is calculated. The LR value calculated is thought to be asymptotically chi-square distributed with the degree of freedom equal to the difference in the number of parameters to be estimated between the alternative and null hypotheses.

### Genetic and epigenetic effect

*A*

_{1}

*A*

_{1},

*A*

_{1}

*A*

_{2}, and

*A*

_{2}

*A*

_{2}, prior to DNA methylation. Let

*a*denote the additive effect of the nucleotide site due to the substitution of allele

*A*

_{1}by

*A*

_{2}or vice versa and

*d*denote the dominant effect due to the interaction between the two alleles. The values of three genotypes are diagrammed over an axis as follows:

*A*

_{1}is assumed to be methylated into the epiallele

*A*

_{ e }. The values of six distinguishable genetic and epigenetic types are expressed as

where the genotypic value of the trait is decomposed into different components, i.e., the overall mean (*μ*), the additive effects due to the substitution of allele *A*_{1} (*a*_{1}) and epiallele *A*_{
e
} by allele *A*_{2} (*a*_{
e
}), and the dominance effects due to the interaction between allele *A*_{1} and epiallele *A*_{
e
} (*d*_{1e}), between allele *A*_{1} and allele *A*_{2} (*d*_{12}) and between allele *A*_{2} and epiallele *A*_{
e
} (*d*_{2e}).

*y*

_{ i }denote the phenotypic value of the trait for individual

*i*(

*i*=1, …,

*n*) in the study population. The MLEs of the genotypic value for each genotype/epigenotype can be obtained by simply taking its mean over all individuals belonging to this genotype/epigenotye (9). The genetic and epigenetic effects can be estimated by solving a group of regular equations for the genotypic values (9), i.e.,

Each of these effects (10) – (14) can be tested by the log-likelihood ratio approach. For an epigenetic study, we are more interested in testing the epigenetic effect of the nucleotide site *a*_{
e
} and dominant effects due to the interactions between the alleles and epiallele *d*_{1e} and *d*_{2e}. The log-likelihood ratio test statistics for each hypothesis test is thought of being asymptotically chi-square distributed with the degree of freedom equal to the difference in the number of parameters to be estimated between the alternative and null hypotheses.

### Genetic and epigenetic variation

*α*=

*a*+ (

*q*

*p*)

*d*[20], we derived the overall genetic variance of the trait due to this site as

where *σ*_{
a
}^{2} = 2*pqα*^{2} is the additive genetic variance depending on both *a* and *d*, and *σ*_{
d
}^{2} = (2*pqd*)^{2} is the dominant genetic variance only depending on *d*. Both additive and dominance variances are affected by the relative magnitudes of allele frequencies *p* and *q*. These two variances reach their maximums when two alternative alleles *A*_{1} and *A*_{2} occur at the same frequency.

*m*is the population mean expressed as

These two parameters can be used to assess the contribution of DNA methylation to the total phenotypic variation of a quantitative trait.

### Numerical analysis

In this section, we performed numerical analyses to investigate how epigenetic marks contribute to the heritability of a complex trait. The occurrence of epigenetic marks is described by population genetic parameters including the occurrence rate of the epiallele and its Hardy-Weinberg disequilibria with unmarked alleles. The effect of epigenetic marks can be specified by quantitative genetic parameters including the epigenetic effect of the epiallele and its interactions with other effects. As analyzed above, population genetic parameters (*p*, *q*, *u*, *D*_{1e}, *D*_{2e}, *D*_{12}) and quantitative genetic parameters (*a*_{1}, *a*_{
e
}, *d*_{1e}, *d*_{2e}, *d*_{12}) contribute to the genetic variance in a complex way (16). We will analyze the contribution of epigenetic marks by separately investigating how these population and quantitative genetic parameters affect *R*_{
e
}^{2}.

### Population genetic effect

*A*

_{1}and

*A*

_{2}, one of which, say

*A*

_{1}, is methylated at a rate

*u*(

*u*takes any value in [0,1]). This methylation may violate the previous HWE assumption. Based on a simple algebraic analysis, we obtain the intervals of

*D*

_{1e},

*D*

_{2e}and

*D*

_{12}as follows:

### Quantitative genetic effect

*a*

_{ e }formed by the epiallele brings about considerable epigenetic variance (Figure 3). This influence increases with increasing

*a*

_{ e }values. The epigenetic variance is also remarkably affected by the dominant effect between the original alleles and epiallele (Figure 4). It is clear that these effect parameters contribute to the epigenetic variance also through their complex interactions.

### Computer simulation

**MLEs of population and quantitative genetic parameters from simulated data with different heritabilities (**
H
^{
2
}
**) and sample sizes (**
n
**)**

True | H | H | H | ||||
---|---|---|---|---|---|---|---|

MLE SD | MLE SD | MLE SD | |||||

| 0.1 | 0.099 (0.019) | 0.100 (0.017) | 0.099 (0.020) | |||

| |||||||

| 0.4 | 0.399 (0.020) | 0.400 (0.022) | 0.403 (0.018) | |||

| 0.01 | 0.011 (0.010) | 0.008 (0.011) | 0.009 (0.012) | |||

| 0.01 | 0.010 (0.003) | 0.010 (0.003) | 0.010 (0.003) | |||

| 0.01 | 0.010 (0.004) | 0.010 (0.005) | 0.010 (0.004) | |||

| 1 | 1.002 (0.096) | 1.009 (0.066) | 1.002 (0.043) | |||

| 0.2 | 0.201 (0.113) | 0.193 (0.085) | 0.198 (0.049) | |||

| 0.05 | 0.060 (0.181) | 0.064 (0.134) | 0.054 (0.080) | |||

| 0.05 | 0.050 (0.076) | 0.049 (0.055) | 0.049 (0.032) | |||

| 0.05 | −0.015 (0.485) | −0.008 (0.401) | 0.010 (0.267) | |||

| 0.05 | 0.027 (0.279) | 0.047 (0.171) | 0.042 (0.116) | |||

| 0.1 | 0.101 (0.014) | 0.101 (0.013) | 0.102 (0.013) | |||

| |||||||

| 0.4 | 0.401 (0.012) | 0.400 (0.012) | 0.401 (0.011) | |||

| 0.01 | 0.010 (0.007) | 0.009 (0.007) | 0.010 (0.007) | |||

| 0.01 | 0.010 (0.003) | 0.010 (0.002) | 0.010 (0.002) | |||

| 0.01 | 0.010 (0.003) | 0.010 (0.003) | 0.010 (0.003) | |||

| 1 | 1.003 (0.053) | 0.996 (0.039) | 1.000 (0.027) | |||

| 0.2 | 0.202 (0.067) | 0.207 (0.049) | 0.200 (0.031) | |||

| 0.05 | 0.051 (0.099) | 0.037 (0.068) | 0.050 (0.050) | |||

| 0.05 | 0.051 (0.048) | 0.047 (0.035) | 0.051 (0.023) | |||

| 0.05 | 0.056 (0.269) | 0.046 (0.191) | 0.038 (0.122) | |||

| 0.05 | 0.048 (0.158) | 0.057 (0.111) | 0.054 (0.081) |

_{0}:

*a*

_{ e }=

*d*

_{1e}=

*d*

_{2e}= 0 vs. H

_{1}: at least one of the effects in the H

_{0}is not equal to zero, and comparing the resulting log-likelihood ratio test statistic with the critical threshold of a chi-square distribution with three degrees of freedom. The proportion of the number of simulation replicates that reject the null hypothesis over the total number of simulation replicates is empirically used as the power of the model. The power of epigenetic effect detection is very sensitive to the magnitude of the epigenetic effect, heritability and sample size (Table 2). When the epigenetic effect is small, the model has low power to detect it, although the power increases with increasing heritability and sample size. To detect a small epigenetic effect, a large sample size (2000 or more) is required for a precisely measured phenotype (with a large heritability). For a medium-size epigenetic effect, a sample size 1000 may be adequate for its detection if then phenotype is precisely measured. In general, the model has reasonably small false positive rates even for a medium sample size (Table 2).

**The power of epigenetic-effect detection by the epigenetic model and its false positive rates (FPR) under different sample sizes (**
n
**) and heritabilities (**
H
^{
2
}
**)**

n | ae= d | H | H | H | |
---|---|---|---|---|---|

Power | 400 | 0.05 | 0.055 | 0.090 | 0.160 |

1000 | 0.05 | 0.090 | 0.125 | 0.355 | |

2000 | 0.05 | 0.115 | 0.205 | 0.630 | |

5000 | 0.05 | 0.215 | 0.415 | 0.975 | |

1000 | 0.1 | 0.085 | 0.255 | 0.780 | |

2000 | 0.1 | 0.265 | 0.525 | 0.975 | |

5000 | 0.1 | 0.495 | 0.950 | 1.00 | |

FPR | 400 | 0.05 | 0.050 | 0.045 | 0.065 |

1000 | 0.05 | 0.060 | 0.025 | 0.045 | |

2000 | 0.05 | 0.030 | 0.010 | 0.045 | |

5000 | 0.05 | 0.085 | 0.050 | 0.070 | |

1000 | 0.1 | 0.045 | 0.040 | 0.040 | |

2000 | 0.1 | 0.055 | 0.025 | 0.030 | |

5000 | 0.1 | 0.050 | 0.020 | 0.045 |

### Implementing the epigenetic model into GWAS

*i*by considering its multifactorial determinants, expressed as

where *ξ*_{i 1}, …, *ξ*_{i 5} are the indicator variable for subject *i* that corresponds to a specific genetic or epigenetic effect at a methylated site, *u*_{
ir
} (*r* = 1*, …, R*) is the value of the *r* th continuous covariate, such as age and BMI, for subject *i*, *α*_{
r
} is the effect of the *r* th continuous covariate, *v*_{
sl
} (*l* = 1*, …, L*_{
s
}*, s* = 1*, …, S*) is the effect of the *l* th level for the *s* th discrete covariate, such as race, gender, and treatment, with ∑ _{l=1}^{
Ls
}*υsl* = 0 where *L*_{
s
} is the number of levels for the *s* th discrete covariate, *x*_{
isl
} is an indicator variable of subject *i* who receives the *l* th level of the *s* th discrete covariate, and *e*_{
i
} is a random error.

A standard multiple linear regression approach can be used to estimate all the effects described in model (19). If the test is made individually for each of the methylated sites, the significance of each effect should be adjusted by multiple comparison approaches such as Bonferroni or FDR.

Analysis of one single methylated site at a time is limited for statistical inference about a comprehensive picture of the genetic and epigenetic architecture of complex phenotypes. The best way such a picture is illustrated is to analyze all sites simultaneously. Li et al. [24] proposed a new approach by incorporating the least absolute shrinkage and selection operator (lasso) [25] to simultaneously analyze a larger number of variables using a much smaller sample size. A detailed algorithm for the Bayesian lasso has been derived [24] and can be readily implemented to GWAS aimed to identify epige-netic variants.

## Discussion

Epigenetic alternations have been increasingly recognized to play an important role in generating and maintaining quantitative genetic variation for complex phenotypes underlying physiology and diseased [6, 7, 9, 26–28]. Preliminary estimates in plants suggest that it can account for up to 30% of the variation in commonly studied phenotypes such as height and flowering time [8]. Many theoretical models have been available to analyze the contributions of epigenetic marks to missing heritability in genome-wide association studies (GWAS) [14–18]. In this article, we extended Mendelian inheritance-based genetic principles to derive a quantitative framework by which to analyze the pattern of how DNA methylation contributes to overall genetic variance. By defining several epigenetic effect parameters, the analytical framework allows the mechanistic characterization of epigenetic actions within the quantitative genetic context.

Through numerical analysis, a small incidence of DNA methylation as well as a small effect due to methylation alternations could lead to a substantial increase of genetic variance, suggesting that epigenetic marks may be an important cause for genetic diversity in nature. Given our finding, the neglection of epigenetic variants in many current GWAS may partly explain the problem of missing heritability [17]. Simulation studies suggest that the model can provide reasonable estimates of epigenetic effect parameters with a sample size of 200 – 400, even when the trait studied has a small heritability. It should be pointed out, however, that this conclusion is based on a well-controlled study in which there are few background noises. For the GWAS in humans, the estimated genetic variation is likely to be confounded by many factors, such as population structure, heterogeneous genetic background, demographic complexity, and highly noisy phenotypic measurements among others. To remove these confounding effects from genetic and epigenetic analysis, a considerably large sample size may be needed.

The model only considers a single methylated site. However, there is no technical difficulty in extending the model to explore two or more sites at the same time which may interact with each other to produce a complex network of epistasis [29]. For two methylated sites, a total of 25 interaction parameters are formed between parameter sets each composed of (*a*_{1}, *a*_{
e
}, *d*_{1e}, *d*_{2e}, *d*_{12}) for each site. In this case, an exponentially increasing sample size and more precise phenotypic measurement (aimed to increase the trait’s heritability) are needed. For the methylated population, originally existing HWE assumption may be violated in which case it is not possible to use gametic linkage disequilibria to specify the association between the two sites. Wu et al. [30] proposed a robust approach to analyze the marker-marker association by deriving a so-called zygotic linkage disequilibrium model. Wu et al.’s approach can be incorporated to identify the contribution of epigenetic marks at two sites to the overall genetic variance.

Epigenetic changes may be an adaptation to environmental perturbations [5, 17, 28]. Thus, it is crucial to incorporate the epigenetic model into a genotype-environment interaction study. By doing so, we can identify which and how epigenetic effects interact with the environment to determine final phenotypes so that the genetic etiology of quantitative variation can be better elucidated. In addition, there is a considerable body of evidence that epigenetic effects may transmitted from one generation to next [31, 32], although other studies found the reprogramming of epigenetic effects during meiosis [5, 33, 34]. By embedding our epigenetic model into a family-based design, we can develop a powerful approach to test the relative importance of these two phenomena in trait control [35–37]. Traditional models analyze the inheritance of quantitative traits based on Mendel’s laws, failing to study the contribution of epigenetic modifications. In addition, many GWAS are based on a case–control study in which genotype frequencies are compared between two groups. To study the association between epigenetic effects and a particular disease, such as cancer, we can incorporate quantitative epigenetic models as described by equations (10) – (14) into a case–control framework, allowing each effect to be tested. The integration of general quantitative genetic models and a case–control design has been discussed and its statistical properties investigated through analytical derivations and computer simulations [38–40]. With these extensions, the new model proposed in this article by integrating traditional quantitative genetic theory and the latest discoveries of epigenetic effects will allow geneticists to chart a more comprehensive picture of the genetic landscape for complex phenotypes underlying agricultural production, physiology and human diseases.

## Declarations

### Acknowledgements

This work is partially supported by NSF/IOS-0923975, NIH/UL1RR0330184 and the Nantong “Jianghai Elites” program.

## Authors’ Affiliations

## References

- Rutherford SL, Henikoff S: Quantitative epigenetics.
*Nat Genet*2003, 33: 6–8. 10.1038/ng0103-6View ArticlePubMed - Richards EJ: Inherited epigenetic variation–revisiting soft inheritance.
*Nat Rev Genet*2006, 7: 395–401.View ArticlePubMed - Richard EJ: Quantitative epigenetics: DNA sequence variation need not apply.
*Genes Dev*2009, 23: 1601–1605. 10.1101/gad.1824909View Article - Richards EJ: Natural epigenetic variation in plant species: a view from the field.
*Curr Opin Plant Biol*2011, 14: 204–209. 10.1016/j.pbi.2011.03.009View ArticlePubMed - Richards CL, Bossdorf O, Pigliucci M: What role does heritable epigenetic variation play in phenotypic evolution?
*Bioscience*2010, 60: 232–237. 10.1525/bio.2010.60.3.9View Article - Feinberg AP: Phenotypic plasticity and the epigenetics of human disease.
*Nature*2007, 447: 433–440. 10.1038/nature05919View ArticlePubMed - Feinberg AP, Irizarry RA: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease.
*Proc Natl Acad Sci USA*2010, 107: 1757–1764. 10.1073/pnas.0906183107PubMed CentralView ArticlePubMed - Johannes F, Porcher E, Teixeira FK, Saliba-Colombani V, Simon M, Agier N, Bulski A, Albuisson J, Heredia F, Audigier P, Bouchez D, Dillmann C, Guerche P, Hospital F, Colot V: Assessing the impact of transgenerational epigenetic variation on complex traits.
*PLoS Genet*2009, 5: e1000530. 10.1371/journal.pgen.1000530PubMed CentralView ArticlePubMed - Eichten SR, Swanson-Wagner RA, Schnable JC, Waters AJ, Hermanson PJ, Liu S, Yeh CT, Jia Y, Gendler K, Freeling M, Schnable PS, Vaughn MW, Springer NM: Heritable epigenetic variation among maize inbreds.
*PLoS Genet*2011, 7(11):e1002372. 10.1371/journal.pgen.1002372PubMed CentralView ArticlePubMed - Johannes F, Colot V, Jansen RC: Epigenome dynamics: a quantitative genetics perspective.
*Nat Rev Genet*2008, 9: 883–890. 10.1038/nrg2467View ArticlePubMed - Maher B: Personal genomes: the case of the missing heritability.
*Nature*2008, 456: 18–21.View ArticlePubMed - Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM: Finding the missing heritability of complex diseases.
*Nature*2009, 461: 747–753. 10.1038/nature08494PubMed CentralView ArticlePubMed - Eichler E, Flint J, Gibson G, Kong A, Leal S, Moore JH, Nadeau JH: Missing heritability and strategies for finding the underlying causes of complex disease.
*Nat Rev Genet*2010, 11: 446–450. 10.1038/nrg2809PubMed CentralView ArticlePubMed - Slatkin M: Epigenetic inheritance and the missing heritability problem.
*Genetics*2009, 182: 845–850. 10.1534/genetics.109.102798PubMed CentralView ArticlePubMed - Tal O, Kisdi E, Jablonka E: Epigenetic contribution to covariance between relatives.
*Genetics*2010, 184: 1037–1050. 10.1534/genetics.109.112466PubMed CentralView ArticlePubMed - Johannes F, Colome-Tatche M: Quantitative epigenetics through epigenomic perturbation of isogenic lines.
*Genetics*2011, 188: 215–227. 10.1534/genetics.111.127118PubMed CentralView ArticlePubMed - Furrow RE, Christiansen FB, Feldman MW: Environment-sensitive epigenetics and the heritability of complex diseases.
*Genetics*2011, 189: 1377–1387. 10.1534/genetics.111.131912PubMed CentralView ArticlePubMed - Jaffe AE, Feinberg AP, Irizarry RA, Leek JT: Significance analysis and statistical dissection of variably methylated regions.
*Biostatistics*2012, 13: 166–178. 10.1093/biostatistics/kxr013PubMed CentralView ArticlePubMed - Roux F, Colome-Tatche M, Edelist C, Warenaar R, Guerche P, Hospital F, Colot V, Jansen RC, Johannes F: Genome-wide epigenetic perturbation jump-starts patterns of heritable variation found in nature.
*Genetics*2011, 188: 1015–1017. 10.1534/genetics.111.128744PubMed CentralView ArticlePubMed - Falconer DS, Mackay TFC:
*Introduction to Quantitative Genetics*. London: Longman; 1996. - Lynch M, Walsh B:
*Genetics and Analysis of Quantitative Traits*. Sunderland, MA: Sinauer Associates; 1998. - Self SG, Liang KY: Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions.
*J Am Stat Assoc*1987, 82: 605–610. 10.1080/01621459.1987.10478472View Article - Andrews DWK: Testing when a parameter is on the boundary of the maintained hypothesis.
*Econometrica*2001, 69: 683–734. 10.1111/1468-0262.00210View Article - Tibshirani R: Regression shrinkage and selction via the lasso.
*J R Stat Soc Ser B*1996, 58: 267–288. - Li JH, Das K, Fu GF, Li RZ, Wu RL: The Bayesian lasso for genome-wide association studies.
*Bioinformatics*2011, 27: 516–523. 10.1093/bioinformatics/btq688PubMed CentralView ArticlePubMed - Feinberg AP, Tycko B: The history of cancer epigenetics.
*Nat Rev Cancer*2004, 4: 143–153.View ArticlePubMed - Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P,
*et al*.: Personalized epigenomic signatures that are stable over time and covary with body mass index.*Sci Transl Med*2011, 3(65):65er1. - Petronis A: Epigenetics as a unifying principle in the aetiology of complex traits and diseases.
*Nature*2010, 465: 721–727. 10.1038/nature09230View ArticlePubMed - Smith LM, Weigel D: On epigenetics and epistasis: hybrids and their non-additive interactions.
*EMBO J*2012, 31: 249–250.PubMed CentralView ArticlePubMed - Wu S, Yang J, Wu RL: Genetic mapping of quantitative trait loci in a non-equilibrium population.
*Stat Appl Mol Genet Biol*2010, 9(1):32. - Reik W: The Wellcome Prize Lecture. Genetic imprinting: the battle of the sexes rages on.
*Exp Physiol*1996, 81: 161–172.View ArticlePubMed - Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian development.
*Science*2001, 293: 1089–1093. 10.1126/science.1063443View ArticlePubMed - Youngson NA, Whitelaw E: Transgenerational epigenetic effects.
*Annu Rev Genomics Hum Genet*2008, 9: 233–257. 10.1146/annurev.genom.9.081307.164445View ArticlePubMed - Whitelaw NC, Whitelaw E: Transgenerational epigenetic inheritance in health and disease.
*Curr Opin Genet Dev*2008, 18: 273–279. 10.1016/j.gde.2008.07.001View ArticlePubMed - Wang C, Wang Z, Luo J, Li Q, Li Y, Ahn K, Prows DR, Wu R: A model for transgenerational imprinting variation in complex traits.
*PLoS One*2010, 5(7):e11396. 10.1371/journal.pone.0011396PubMed CentralView ArticlePubMed - Wang CG, Wang Z, Prows DR, Wu RL: A computational framework for the inheritance of genomic imprinting for complex traits.
*Brief Bioinform*2012, 13: 34–45. 10.1093/bib/bbr023PubMed CentralView ArticlePubMed - Li Y, Guo YQ, Hou W, Chang M, Liao LP, Wu RL: A statistical design for testing transgenerational genomic imprinting in natural human populations.
*PLoS One*2011, 6(2):e16858. 10.1371/journal.pone.0016858PubMed CentralView ArticlePubMed - Wang Z, Liu T, Lin Z, Hegarty J, Koltun WA, Wu R: A general model for multilocus epistatic interactions in case–control studies.
*PLoS One*2010, 5(8):e11384. 10.1371/journal.pone.0011384PubMed CentralView ArticlePubMed - Liu T, Thalamuthu A, Liu JJ, Chen C, Wang Z, Wu R: Asymptotic distribution for epistatic tests in case–control studies.
*Genomics*2011, 98: 145–151. 10.1016/j.ygeno.2011.05.001View ArticlePubMed - Zhang L, Liu R, Wang Z, Culver DA, Wu R: Modeling haplotype-haplotype interactions in case–control genetic association studies.
*Front Genet*2012, 3: 2.PubMed CentralPubMed

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.